Kopin (KOPN) 10-Q 7 May 20 2020 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 28, 2020	May 06, 2019
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 28, 2020
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020
Current Fiscal Year End Date	--12-26
Entity File Number	0-19882
Entity Registrant Name	KOPIN CORPORATION
Entity Central Index Key	0000771266
Entity Tax Identification Number	04-2833935
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	125 North Drive
Entity Address, City or Town	Westborough
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01581-3335
City Area Code	(508)
Local Phone Number	870-5959
Title of 12(b) Security	Common Stock, par value $0.01
Trading Symbol	KOPN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		84,910,288

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 28, 2020	Dec. 28, 2019
Current assets:
Cash and equivalents	$ 8,333,603	$ 6,029,247
Marketable debt securities, at fair value	9,307,959	15,752,997
Accounts receivable, net of allowance of $786,000 in 2020 and $938,000 in 2019	5,929,983	6,023,250
Contract assets and unbilled receivables	1,394,633	921,082
Inventory	3,427,507	3,768,696
Prepaid taxes	82,088	104,442
Prepaid expenses and other current assets	1,403,729	1,164,927
Total current assets	29,879,502	33,764,641
Property, plant and equipment, net	1,450,328	1,473,341
Operating lease right-of-use assets	2,506,159	2,753,963
Other assets	253,750	517,411
Equity investments	4,346,642	4,537,159
Total assets	38,436,381	43,046,515
Current liabilities:
Accounts payable	3,925,184	3,998,234
Accrued payroll and expenses	1,699,527	2,203,773
Accrued warranty	508,000	509,000
Contract liabilities and billings in excess of revenues earned	1,229,396	796,794
Operating lease liabilities	1,059,429	1,041,695
Other accrued liabilities	1,684,547	2,235,217
Taxes payable	503,000	525,000
Total current liabilities	10,609,083	11,309,713
Noncurrent contract liabilities and asset retirement obligations	251,935	268,440
Operating lease liabilities, net of current portion	1,513,520	1,791,590
Other long-term obligations	1,067,389	1,085,160
Commitments and contingencies (Note 13)
Stockholders’ equity:
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued
Common stock, par value $.01 per share: authorized, 120,000,000 shares; issued 89,427,296 shares in 2020 and 88,912,796 shares in 2019; outstanding 82,536,416 in 2020 and 2019	870,496	870,496
Additional paid-in capital	344,615,002	344,456,537
Treasury stock (4,513,256 shares in 2020 and 2019, at cost)	(17,238,669)	(17,238,669)
Accumulated other comprehensive income	1,658,552	1,757,184
Accumulated deficit	(304,832,432)	(301,236,913)
Total Kopin Corporation stockholders’ equity	25,072,949	28,608,635
Noncontrolling interest	(78,495)	(17,023)
Total Kopin Corporation stockholders’ equity	24,994,454	28,591,612
Total liabilities and stockholders’ equity	$ 38,436,381	$ 43,046,515

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 28, 2020	Dec. 28, 2019
Statement of Financial Position [Abstract]
Accounts Receivable, Allowance for Credit Loss, Current	$ 786,000	$ 938,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Authorized	3,000	3,000
Preferred Stock, Shares Issued	0	0
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Common Stock, Shares Authorized	120,000,000	120,000,000
Common Stock, Shares, Issued	89,427,296	88,912,796
Common Stock, Shares, Outstanding	82,536,416	82,536,416
Treasury Stock, Shares	4,513,256	4,513,256

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Revenues:
Total revenues	$ 7,878,605	$ 5,542,925
Expenses:
Cost of product revenues	5,647,847	5,877,077
Research and development	2,339,748	4,966,716
Selling, general and administration	3,432,092	6,282,803
Total expenses	11,419,687	17,126,596
Loss from operations	(3,541,082)	(11,583,671)
Other (expense) income:
Interest income	73,406	163,361
Other income (expense), net	12,678	(109,735)
Foreign currency transaction (losses) gains	(172,993)	236,135
Total other income and expense	(86,909)	289,761
Loss before provision for income taxes and net loss (income) attributable to noncontrolling interest	(3,627,991)	(11,293,910)
Tax provision	(29,000)	(26,000)
Net loss	(3,656,991)	(11,319,910)
Net loss (income) attributable to the noncontrolling interest	61,472	(11,017)
Net loss attributable to Kopin Corporation	$ (3,595,519)	$ (11,330,927)
Net loss per share
Basic and diluted	$ (0.04)	$ (0.15)
Weighted average number of common shares outstanding
Basic and diluted	82,536,416	74,968,981
Net Product Revenues [Member]
Revenues:
Total revenues	$ 5,919,206	$ 4,613,856
Research And Development And Other Revenues [Member]
Revenues:
Total revenues	$ 1,959,399	$ 929,069

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Income Statement [Abstract]
Net loss	$ (3,656,991)	$ (11,319,910)
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments	189,078	(122,064)
Unrealized holding (loss) gain on marketable securities	(278,362)	222,000
Reclassification of holding losses in net loss	(9,348)	(2,619)
Other comprehensive (loss) income, net of tax	(98,632)	97,317
Comprehensive loss	(3,755,623)	(11,222,593)
Comprehensive loss (income) attributable to the noncontrolling interest	61,472	(11,017)
Comprehensive loss attributable to Kopin Corporation	$ (3,694,151)	$ (11,233,610)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income [Member]	Accumulated Deficit [Member]	Total Corporation Stockholders Equity [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 29, 2018	$ 785,220	$ 334,491,397	$ (17,238,669)	$ 1,554,587	$ (271,730,661)	$ 47,861,874	$ (149,053)	$ 47,712,821
Beginning balance, shares at Dec. 29, 2018	78,522,066
Stock-based compensation expense		815,842				815,842		815,842
Other comprehensive income (loss)				97,317		97,317		97,317
Vesting of restricted stock	$ 100	(100)
Vesting of restricted stock, shares	10,000
Repurchases of restricted stock to satisfy tax withholding obligations	$ (43)	(7,085)				(7,128)		(7,128)
Repurchases of restricted stock to satisfy tax withholding obligations, shares	(4,294)
Sale of registered stock	$ 72,727	7,237,273				7,310,000		7,310,000
Sale of registered stock, shares	7,272,727
Net (loss) income					(11,330,927)	(11,330,927)	11,017	(11,319,910)
Ending balance, value at Mar. 30, 2019	$ 858,004	342,537,327	(17,238,669)	1,651,904	(283,061,588)	44,746,978	(138,036)	44,608,942
Ending balance, shares at Mar. 30, 2019	85,800,499
Beginning balance, value at Dec. 28, 2019	$ 870,496	344,456,537	(17,238,669)	1,757,184	(301,236,913)	28,608,635	(17,023)	28,591,612
Beginning balance, shares at Dec. 28, 2019	87,049,672
Stock-based compensation expense		158,465				158,465		158,465
Other comprehensive income (loss)				(98,632)		(98,632)		(98,632)
Net (loss) income					(3,595,519)	(3,595,519)	(61,472)	(3,656,991)
Ending balance, value at Mar. 28, 2020	$ 870,496	$ 344,615,002	$ (17,238,669)	$ 1,658,552	$ (304,832,432)	$ 25,072,949	$ (78,495)	$ 24,994,454
Ending balance, shares at Mar. 28, 2020	87,049,672

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Cash flows from operating activities:
Net loss	$ (3,656,991)	$ (11,319,910)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	170,805	264,389
Accretion of premium or discount on marketable debt securities	2,344
Stock-based compensation	158,465	815,842
Foreign currency losses (gains)	193,073	(233,180)
Change in allowance for bad debt	(150,500)	246,970
Loss on disposal of plant and equipment		180,308
Write-off of excess inventory	676,063	1,253,988
Other non-cash items	(985)	32,732
Changes in assets and liabilities:
Accounts receivable	260,602	(953,353)
Contract assets	(473,551)	947,986
Inventory	(356,766)	(620,982)
Prepaid expenses and other current assets	(33,168)	221,926
Accounts payable and accrued expenses	(1,086,534)	393,941
Billings in excess of revenue earned	428,688	922,540
Net cash used in operating activities	(3,868,455)	(7,846,803)
Cash flows from investing activities:
Other assets	55,231	(50,000)
Capital expenditures	(155,930)	(74,920)
Proceeds from sale of marketable debt securities	6,297,500	2,789,139
Net cash provided by investing activities	6,196,801	2,664,219
Cash flows from financing activities:
Sale of registered stock		7,450,000
Settlements of restricted stock for tax withholding obligations		(7,128)
Net cash provided by financing activities		7,442,872
Effect of exchange rate changes on cash	(23,990)	(3,110)
Net increase in cash and cash equivalents	2,304,356	2,257,178
Cash and cash equivalents:
Beginning of period	6,029,247	14,326,347
End of period	8,333,603	16,583,525
Supplemental disclosure of cash flow information:
Issuance costs included in accounts payable and accrued expenses		$ 140,000

BASIS OF PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Mar. 28, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION The condensed consolidated financial statements of Kopin Corporation as of March 28, 2020 and for the three month periods ended March 28, 2020 and March 30, 2019 are unaudited and include all adjustments that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 28, 2019. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. The Company reclassified certain prior period amounts to conform to the current period presentation. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning. Going Concern The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred net losses of $ 29.4 million and net cash outflows from operations of $ 21.0 million for the fiscal year ended 2019. The Company incurred a net loss of $ 3.6 million for the three months ended March 28, 2020 and net cash outflows from operations of $ 3.9 million. In addition, the Company has experienced a significant decline in its cash and cash equivalents and marketable debt securities over the last several years, which was primarily a result of funding operating losses, of which a significant component relates to the Company’s ongoing investments in the research and development of Wearable products. The Company had $ 17.6 million of cash and cash equivalents and marketable debt securities at March 28, 2020. The Company’s historical and current use of cash in operations combined with limited liquidity resources raise substantial doubt regarding the Company’s ability to continue as a going concern. The Company’s products are targeted towards the military and industrial wearable market. Management believes the industrial wearable market is still developing and cannot predict how long it will take to develop or if the Company’s products will be accepted. In addition, the Company’s current strategy is to continue to invest in research and development, even during unprofitable periods, which may result in the Company continuing to incur net losses and negative cash flows from operations. If the Company is unable to achieve and maintain positive cash flows and profitability in the foreseeable future, its financial condition may ultimately be materially adversely affected such that management may be required to reduce operating expenses, including investments in research and development, or raise additional capital. While there can be no assurance the Company will be able to successfully reduce operating expenses or raise additional capital, management believes its historical success in managing cash flows and obtaining capital will continue in the foreseeable future. In March 2020, the World Health Organization declared COVID-19 a pandemic. The COVID-19 pandemic has negatively impacted the global and national economy, disrupted global supply chains, and created significant volatility in and disruption of financial markets. The extent of the impact of the COVID-19 pandemic on the Company’s operational and financial performance, including the ability to execute business strategies and initiatives in the expected time frame, will depend on future developments, including the duration and spread of the pandemic and related restrictions on travel and transportation, all of which are uncertain and cannot be predicted at this time. An extended period of global supply chain and economic disruption could materially affect Kopin’s business, results of operations, financial condition, and access to sources of liquidity. In this regard, the CARES Act established a Paycheck Protection Program, whereby certain small businesses are eligible for a loan to fund payroll expenses, rent, and related costs. The loan may be forgiven if the funds are used for payroll and other qualified expenses. The Company received $ 2.1 The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

ACCOUNTING STANDARDS

ACCOUNTING STANDARDS	3 Months Ended
	Mar. 28, 2020
Accounting Policies [Abstract]
ACCOUNTING STANDARDS	2. ACCOUNTING STANDARDS Accounting Standards Issued But Not Yet Adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments

CASH AND CASH EQUIVALENTS AND M

CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES	3 Months Ended
	Mar. 28, 2020
Cash and Cash Equivalents [Abstract]
CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES	3. CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents. Marketable debt securities consist primarily of commercial paper, medium-term corporate notes, and U.S. government and agency backed securities. The Company classifies these marketable debt securities as available-for-sale at fair value in “Marketable debt securities, at fair value.” The Company records the amortization of premium and accretion of discounts on marketable debt securities in the results of operations. The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses with respect to marketable debt securities. The gross gains and losses realized related to sales and maturities of marketable debt securities were not material during the three months ended March 28, 2020 and March 30, 2019. Investments in available-for-sale marketable debt securities were as follows at March 28, 2020 and December 28, 2019: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Gains Unrealized Losses Fair Value 2020 2019 2020 2019 2020 2019 2020 2019 U.S. government and agency backed securities $ 3,005,799 $ 8,304,229 $ 32,301 $ - $ - $ (7,359 ) $ 3,038,100 $ 8,296,870 Corporate debt 6,457,883 7,459,298 - - (188,024 ) (3,171 ) 6,269,859 7,456,127 Total $ 9,463,682 $ 15,763,527 $ 32,301 $ - $ (188,024 ) $ (10,530 ) $ 9,307,959 $ 15,752,997 The contractual maturity of the Company’s marketable debt securities was as follows at March 28, 2020: SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One year One to Five years Total U.S. government and agency backed securities $ - $ 3,038,100 $ 3,038,100 Corporate debt 2,529,970 3,739,889 6,269,859 Total $ 2,529,970 $ 6,777,989 $ 9,307,959

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Mar. 28, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	4. FAIR VALUE MEASUREMENTS Financial instruments are categorized as Level 1, Level 2 or Level 3 based upon the method by which their fair value is computed. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates, yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets. The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS Fair Value Measurement March 28, 2020 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 8,333,603 $ 8,333,603 $ - $ - U.S. Government Securities 3,038,100 - 3,038,100 - Corporate Debt 6,269,859 - 6,269,859 - Equity Investments 4,346,642 244,194 - 4,102,448 $ 21,988,204 $ 8,577,797 $ 9,307,959 $ 4,102,448 Fair Value Measurement at December 28, 2019 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 6,029,247 $ 6,029,247 $ - $ - U.S. Government Securities 8,296,870 - 8,296,870 - Corporate Debt 7,456,127 - 7,456,127 - Equity Investments 4,537,159 386,711 - 4,150,448 $ 26,319,403 $ 6,415,958 $ 15,752,997 $ 4,150,448 Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows: SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION December 28, 2019 Net unrealized losses Purchases, issuances and settlements Transfers in and or out of Level 3 March 28, 2020 Equity Investments $ 4,537,159 $ (190,517) $ - $ $ 4,346,642 The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value because of their short-term nature. If accrued liabilities were carried at fair value, these would be classified as Level 2 in the fair value hierarchy. Marketable Debt Securities The corporate debt consists of floating rate notes with a maturity that is over multiple years but has interest rates that are reset every three months based on the then-current three-month London Interbank Offering Rate (“three-month Libor”). The Company validates the fair market values of the financial instruments above by using discounted cash flow models, obtaining independent pricing of the securities or through the use of a model that incorporates the three-month Libor, the credit default swap rate of the issuer and the bid and ask price spread of the same or similar investments which are traded on several markets. Equity Investments The Company acquired an equity interest in a company in the first quarter of 2018. The Company made a $ 1.0 million capital contribution during the three months ended March 31, 2018. The Company also contributed certain intellectual property. During the three months ended March 28, 2020, the Company recorded a $ 0.1 million unrealized loss on this equity investment due to a fluctuation in the foreign exchange rate. As of March 28, 2020, the Company owned an 11% interest in this investment and the fair value of this equity investment was $ 3.5 million at March 28, 2020. In 2017 the Company had a warrant to acquire up to 15% of the next round of equity offered by a customer as part of the licensing of technology to the customer. The Company used the pricing and terms of the qualified financing round by the customer in determining the value of its Series A warrant and recorded a gain of $ 2.0 million. The Company acquired an equity interest in the customer by exercising the Series A warrant into Series A shares in the second quarter of 2018 and recorded a loss of less than $ 0.1 million. In addition, the Company acquired shares of the customer’s Series B shares valued at $ 2.5 million based on the fair value of the Series B at the closing in May 2019. During the second quarter of 2019, the Company recognized a $ 0.8 million gain based on an observable price change for the Series A shares by using the customer’s Series B capital structure, pricing of the shares being offered and the liquidation preference of Series B. In the fourth quarter of 2019 the Company reviewed the financial condition and other factors of the customer and as a result, recorded an impairment charge of $ 5.2 million to reduce our investment in the customer to zero. On September 30, 2019 the Company entered into an Asset Purchase Agreement (the “Solos Purchase Agreement”) pursuant to which the Company sold and licensed certain assets of our Solos TM TM 20.0% equity stake in Solos Incorporation (“Solos Inc.”). The Company did not have an observable price change for similar investments of its equity investments and recorded no impairment charges on its equity investments during the three months ended March 28, 2020.

INVENTORY

INVENTORY	3 Months Ended
	Mar. 28, 2020
Inventory Disclosure [Abstract]
INVENTORY	5. INVENTORY Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at March 28, 2020 and December 28, 2019: SCHEDULE OF INVENTORY March 28, 2020 December 28, 2019 Raw materials $ 2,522,612 $ 2,630,156 Work-in-process 495,477 711,475 Finished goods 409,418 427,065 Total $ 3,427,507 $ 3,768,696

NET LOSS PER SHARE

NET LOSS PER SHARE	3 Months Ended
	Mar. 28, 2020
Net loss per share
NET LOSS PER SHARE	6. NET LOSS PER SHARE Basic net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period less any unvested restricted shares. Diluted net loss per share is calculated using weighted-average shares outstanding and contingently issuable shares, less weighted-average shares reacquired during the period. The net outstanding shares are adjusted for the dilutive effect of shares issuable upon the assumed conversion of the Company’s common stock equivalents, which consist of unvested restricted stock. The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period: SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED Three months ended Three months ended March 28, 2020 March 30, 2019 Non-vested restricted common stock 2,377,624 2,150,874

STOCKHOLDERS_ EQUITY AND STOCK-

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	3 Months Ended
	Mar. 28, 2020
Share-based Payment Arrangement [Abstract]
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	7. STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION Registered sale of equity securities On March 15, 2019, the Company sold 7.3 million shares of registered common stock for gross proceeds of $ 8.0 million ($ 1.10 per share), before deducting underwriting discounts and offering expenses paid by the Company of $ 0.7 million. This represented approximately 8.9% of Kopin’s total outstanding shares of common stock as of the date of purchase. The net proceeds from the offering were used for general corporate purposes, including working capital. On April 10, 2019, the Company sold 0.7 million shares of registered common stock for gross proceeds of $ 0.8 million ($ 1.10 per share), before deducting underwriting discounts and offering expenses paid by the Company of less than $ 0.1 million, pursuant to the partial exercise of the underwriters’ overallotment option in connection with its March 15, 2019 public offering. This represented approximately 0.8% of Kopin’s total outstanding shares of common stock as of the date of purchase. Non-Vested Restricted Common Stock The fair value of non-vested restricted common stock awards is generally the market value of the Company’s common stock on the date of grant. The non-vested restricted common stock awards require the employee to fulfill certain obligations, including remaining employed by the Company for one, two or four years (the vesting period) and in certain cases also require meeting either performance criteria or the Company’s stock achieving a certain price. For non-vested restricted common stock awards that solely require the recipient to remain employed with the Company, the stock compensation expense is amortized over the anticipated service period. For non-vested restricted common stock awards that require the achievement of performance criteria, the Company reviews the probability of achieving the performance goals on a periodic basis. If the Company determines that it is probable that the performance criteria will be achieved, the amount of compensation cost derived for the performance goal is amortized over the anticipated service period. If the performance criteria are not met, no compensation cost is recognized and any previously recognized compensation cost is reversed. Restricted stock activity was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Shares Weighted Average Grant Fair Value Balance, December 28, 2019 1,863,124 $ 1.60 Granted 533,000 0.41 Forfeited (18,500) 1.94 Vested — — Balance, March 28, 2020 2,377,624 $ 1.33 On December 31, 2017, the Company amended the employment agreement with our CEO, Dr. John Fan, to expire on December 31, 2020 and as part of the amendment issued restricted stock grants. Of the restricted stock grants issued to Dr. Fan, 640,000 shares will vest upon the first 20 consecutive trading day period following the grant date during which the Company’s common stock trades at a price equal to or greater than $5.25, 150,000 shares will vest at the end of the first 20 consecutive trading day period following the grant date during which the Company’s common stock trades at a price per share equal to or greater than $6.00, and 150,000 shares will vest at the end of the first 20 consecutive trading day period following the grant date during which the Company’s common stock trades at a price per share equal to or greater than $7.00. All of the grants are subject to certain acceleration events and expire on December 31, 2020 . The total fair value of these awards on December 31, 2017 was $ 1.7 million. The value of restricted stock grants that vest based on market conditions is computed on the date of grant using the Monte Carlo model with the following assumptions: SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS For the three months ended March 28, 2020 Performance price target $ 5.25 $ 6.00 $ 7.00 Expected volatility 48.3 % 48.3 % 48.3 % Interest rate 1.97 % 1.97 % 1.97 % Expected life (years) 3 3 3 Dividend yield — % — % — % Stock-Based Compensation The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three months ended March 28, 2020 and March 30, 2019 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Ended Three Months Ended March 28, 2020 March 30, 2019 Cost of product revenues $ 13,977 $ 32,108 Research and development 55,132 104,730 Selling, general and administrative 89,356 679,004 Total $ 158,465 $ 815,842 Unrecognized compensation expense for non-vested restricted common stock as of March 28, 2020 totaled $ 0.8 million and is expected to be recognized over a weighted average period of approximately two years.

ACCRUED WARRANTY

ACCRUED WARRANTY	3 Months Ended
	Mar. 28, 2020
Guarantees and Product Warranties [Abstract]
ACCRUED WARRANTY	8. ACCRUED WARRANTY The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty. A provision for estimated future costs and estimated returns for credit relating to such warranty is recorded in the period when product is shipped and revenue recognized, and is updated as additional information becomes available. The Company’s estimate of future costs to satisfy warranty obligations is based primarily on historical warranty expense experienced and a provision for potential future product failures. Changes in the accrued warranty for the three months ended March 28, 2020 were as follows: SCHEDULE OF ACCRUED WARRANTY Balance, December 28, 2019 $ 509,000 Additions 225,000 Claims (226,000 ) Balance, March 28, 2020 $ 508,000 Extended Warranties Deferred revenue represents the purchase of extended warranties by the Company’s customers. The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months beyond the standard 12 to 18 month warranty. The Company classifies the current portion of deferred revenue under Other accrued liabilities in its condensed consolidated balance sheets. At March 28, 2020, the Company had less than $ 0.1 million of deferred revenue related to extended warranties.

INCOME TAXES

INCOME TAXES	3 Months Ended
	Mar. 28, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	9. INCOME TAXES The Company recorded a provision for income taxes of less than $ 0.1 million in the three months ended March 28, 2020 and the three months ended March 30, 2019. As of March 28, 2020, the Company has available for tax purposes U.S. federal NOLs of approximately $ 160.5 million expiring 2022 through 2037 and $ 56.9 million that have an unlimited carryover period. The Company had recognized a full valuation allowance on its domestic and certain foreign net deferred tax assets due to the uncertainty of realization of such assets. The Company recognizes both accrued interest and penalties related to its uncertain tax positions related to intercompany loan interest and potential transfer pricing exposure related to its foreign subsidiaries.

CONTRACT ASSETS AND LIABILITIES

CONTRACT ASSETS AND LIABILITIES	3 Months Ended
	Mar. 28, 2020
Contract Assets And Liabilities
CONTRACT ASSETS AND LIABILITIES	10. CONTRACT ASSETS AND LIABILITIES Contract assets include unbilled amounts typically resulting from sales under contracts when the cost-to-cost method of revenue recognition is utilized and revenue recognized from customer arrangements, including licensing, exceeds the amount billed to the customer, and right to payment is not just subject to the passage of time. Amounts may not exceed their net realizable value. Contract assets are generally classified as current. The Company classifies the noncurrent portion of contract assets under other assets in its condensed consolidated balance sheets. Contract liabilities consist of advance payments and billings in excess of cost incurred and deferred revenue. Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY March 28, 2020 December 28, 2019 $ Change % Change Contract assets—current $ 1,394,633 $ 921,082 $ 473,551 51% Contract liabilities and billings in excess of revenues earned (1,229,396 ) (796,794 ) (432,602 ) 54% Contract liabilities—noncurrent (2,643 ) (6,557 ) 3,914 (60)% Net contract assets (liabilities) $ 162,594 $ 117,731 $ 44,863 38% The $ 45,000 increase in the Company’s net contract assets (liabilities) at March 28, 2020 as compared to December 28, 2019 was primarily due to an increase in inventory and other costs associated with government contracts which recognize revenue over time, which was partially offset by an increase in billing in excess of revenue earned. In the three months ended March 28, 2020, the Company recognized revenue of $ 0.6 million related to our contract liabilities at December 28, 2019. In the three months ended March 30, 2019, the Company recognized revenue of less than $ 0.1 million related to our contract liabilities at December 29, 2018. The Company did not recognize impairment losses on our contract assets in the three months ended March 28, 2020 or March 30, 2019. Performance Obligations The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS Three months ended Three months ended March 28, 2020 March 30, 2019 Point in time 36% 71% Over time 64% 29% Remaining performance obligations represent the transaction price of orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts (e.g., indefinite-delivery, indefinite-quantity (“IDIQ”)). As of March 28, 2020, the aggregate amount of the transaction price allocated to remaining performance obligations was $ 8.6 million which the Company expects to recognize over the next 13 months. The remaining performance obligations represent amounts to be earned under government contracts, which are subject to cancellation.

LEASES

LEASES	3 Months Ended
	Mar. 28, 2020
Leases [Abstract]
LEASES	11. LEASES The Company enters into operating leases primarily for: real estate, including for manufacturing, engineering, research, administration and sales facilities, and information technology (“IT”) equipment. At March 28, 2020 and December 28, 2019, the Company did not have any finance leases. Approximately all of our future lease commitments, and related lease liability, relate to the Company’s real estate leases. Some of the Company’s leases include options to extend or terminate the lease. The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three months ended Three months ended March 28, 2020 March 30, 2019 Operating lease cost $ 283,000 $ 301,000 At March 28, 2020, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2020 (excluding the three months ended March 28, 2020) $ 893,000 2021 1,050,000 2022 654,000 2023 201,000 Thereafter — Total future lease payments 2,798,000 Less imputed interest (225,000 ) Total $ 2,573,000 The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheet at March 28, 2020 was as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS March 28, 2020 Operating lease liabilities–current $ 1,059,429 Operating lease liabilities–noncurrent 1,513,520 Total lease liabilities $ 2,572,949 Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Three months ended March 28, 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 295,000 Other information related to leases was as follows: March 28, 2020 Weighted Average Discount Rate–Operating Leases 6.16% Weighted Average Remaining Lease Term–Operating Leases (in years) 2.61

SEGMENTS AND DISAGGREGATION OF

SEGMENTS AND DISAGGREGATION OF REVENUE	3 Months Ended
	Mar. 28, 2020
Segment Reporting [Abstract]
SEGMENTS AND DISAGGREGATION OF REVENUE	12. SEGMENTS AND DISAGGREGATION OF REVENUE We continually monitor and review our segment reporting structure in accordance with authoritative guidance to determine if any changes have occurred that would affect our reportable segments. In the fourth quarter of 2019, as a result of the changes in our operations and management structure we commenced reporting one segment. We have retrospectively adjusted our segment disclosures to present one reportable segment , as our Chief Executive Officer, who is our chief operating decision maker (“CODM”), reviews results on a total company basis. Total long-lived assets by country at March 28, 2020 and December 28, 2019 were: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) March 28, 2020 December 28, 2019 U.S. $ 3,461 $ 3,647 United Kingdom 379 442 China 30 37 Japan 86 102 Total $ 3,956 $ 4,228 We disaggregate our revenue from contracts with customers by geographic location and by display application, as we believe it best depicts how the nature, amount, timing and uncertainty of our revenue and cash flows are affected by economic factors. During the three months ended March 28, 2020 and March 30, 2019, the Company derived its sales from the following geographies: SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE March 28, 2020 March 30, 2019 (In thousands, except percentages) Revenue % of Total Revenue % of Total United States $ 6,765 86 % $ 2,406 43 % Other Americas 101 1 18 — Total Americas 6,866 87 2,424 44 Asia-Pacific 664 8 1,872 34 Europe 348 5 1,247 22 Total Revenues $ 7,878 100 % $ 5,543 100 % During the three months ended March 28, 2020 and March 30, 2019, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT (In thousands) March 28, 2020 March 30, 2019 Military $ 3,513 $ 1,441 Industrial 2,183 2,503 Consumer 222 646 R&D 1,960 929 Other - 24 Total Revenues $ 7,878 $ 5,543

LITIGATION

LITIGATION	3 Months Ended
	Mar. 28, 2020
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	13. LITIGATION The Company may engage in legal proceedings arising in the ordinary course of business. Claims, suits, investigations and proceedings are inherently uncertain and it is not possible to predict the ultimate outcome of such matters and our business, financial condition, results of operations or cash flows could be affected in any particular period. BlueRadios, Inc. v. Kopin Corporation, Civil Action No. 16-02052-JLK (D. Col.): On August 12, 2016, BlueRadios, Inc. (“BlueRadios”) filed a complaint in the U.S. District Court for the District of Colorado, alleging that the Company breached a contract between it and BlueRadios concerning an alleged joint venture between the Company and BlueRadios to design, develop and commercialize micro-display products with embedded wireless technology referred to as “Golden-i” breached the covenant of good faith and fair dealing associated with that contract, breached its fiduciary duty to BlueRadios, and misappropriated trade secrets owned by BlueRadios in violation of Colorado law (C.R.S. § 7-74-104(4)) and the Defend Trade Secrets Act (18 U.S.C. § 1836(b)(1)). BlueRadios further alleges that the Company was unjustly enriched by its alleged misconduct, BlueRadios is entitled to an accounting to determine the amount of profits obtained by the Company as a result of its alleged misconduct, and the inventorship on at least ten patents or patent applications owned by the Company need to be corrected to list BlueRadios’ employees as inventors and thereby list BlueRadios as co-assignees of the patents. BlueRadios seeks monetary, declaratory, and injunctive relief, including for alleged non-payment of engineering retainer fees. On October 11, 2016, the Company filed its Answer and Affirmative Defenses. The parties completed expert depositions on November 15, 2019. On December 2, 2019, the Company filed a Motion for Partial Summary Judgment requesting the Court dismiss counts 2-7 in their entirety and counts 1 and 8 in part. BlueRadios also filed a Motion for Partial Summary Judgment alleging it is the co-owner of U.S. Patent No. 8,909,296. Responses to the Motions for Partial Summary Judgment were filed on January 15, 2020, and replies were filed on February 19, 2020. A trial date has not yet been set by the Court. The Company has not concluded a loss from this matter is probable; therefore, we have not recorded an accrual for litigation or claims related to this matter for the period ended March 28, 2020. The Company will continue to evaluate information as it becomes known and will record an estimate for losses at the time or times when it is both probable that a loss has been incurred and the amount of the loss is reasonably estimable.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 28, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	14. RELATED PARTY TRANSACTIONS The Company may from time to time enter into agreements with stockholders, affiliates and other companies engaged in certain aspects of the display, electronics, optical and software industries as part of our business strategy. In addition, the wearable computing product market is relatively new and there may be other technologies the Company needs to purchase from affiliates to enhance its product offering. During the three month periods ended March 28, 2020 and March 30, 2019, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three months ended Three months ended March 28, 2020 March 30, 2019 Sales Purchases Sales Purchases Goertek $ — $ — $ — $ 1,246,077 Solos Technology 140,068 9,000 — — RealWear, Inc. — — 525,386 — $ 140,068 $ 9,000 $ 525,386 $ 1,246,077 At March 28, 2020 and December 28, 2019, the Company had the following receivables, contract assets and payables with related parties: March 28, 2020 December 28, 2019 Receivables Contract assets Payables Receivables Contract assets Payables Solos Technology $ 173,128 $ — $ 9,000 $ 283,203 — — RealWear, Inc. 396,848 — — 646,848 — — $ 569,976 $ — $ 9,000 $ 930,051 $ — $ —

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 28, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	15. SUBSEQUENT EVENTS On April 21, 2020, the Company received the proceeds from a loan in the amount of approximately $ 2.1 million (the “PPP Loan”) from Rockland Trust Company, as lender, pursuant to the Paycheck Protection Program (“PPP”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). The PPP Loan matures on April 20, 2022 and bears interest at a rate of 1.0% per annum. Commencing November 21, 2020, the Company is required to pay the lender equal monthly payments of principal and interest as required to fully amortize by April 20, 2022 the principal amount outstanding on the PPP Loan as of October 21, 2020. The PPP Loan is evidenced by a promissory note dated April 21, 2020 (the “Note”), which contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. The PPP Loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties. All or a portion of the PPP Loan may be forgiven by the U.S. Small Business Administration (“SBA”) upon application by the Company beginning 60 days but not later than 120 days after loan approval and upon documentation of expenditures in accordance with the SBA requirements. Under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, covered mortgage interest and covered utilities during the eight-week period beginning on the date of loan approval. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee in excess of $ 100,000 , prorated annually. Not more than 25% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $ 100,000 or less annually are reduced by more than 25%. In the event the PPP Loan, or any portion thereof, is forgiven pursuant to the PPP, the amount forgiven is applied to outstanding principal. No assurance is provided that the Company will apply for and obtain forgiveness of the PPP Loan in whole or in part.

CASH AND CASH EQUIVALENTS AND_2

CASH AND CASH EQUIVALENTS AND MARKETABLE DEBT SECURITIES (Tables)	3 Months Ended
	Mar. 28, 2020
Cash and Cash Equivalents [Abstract]
SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES	Investments in available-for-sale marketable debt securities were as follows at March 28, 2020 and December 28, 2019: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Gains Unrealized Losses Fair Value 2020 2019 2020 2019 2020 2019 2020 2019 U.S. government and agency backed securities $ 3,005,799 $ 8,304,229 $ 32,301 $ - $ - $ (7,359 ) $ 3,038,100 $ 8,296,870 Corporate debt 6,457,883 7,459,298 - - (188,024 ) (3,171 ) 6,269,859 7,456,127 Total $ 9,463,682 $ 15,763,527 $ 32,301 $ - $ (188,024 ) $ (10,530 ) $ 9,307,959 $ 15,752,997
SCHEDULE OF MARKETABLE DEBT SECURITIES	The contractual maturity of the Company’s marketable debt securities was as follows at March 28, 2020: SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One year One to Five years Total U.S. government and agency backed securities $ - $ 3,038,100 $ 3,038,100 Corporate debt 2,529,970 3,739,889 6,269,859 Total $ 2,529,970 $ 6,777,989 $ 9,307,959

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Mar. 28, 2020
Fair Value Disclosures [Abstract]
SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS	The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS Fair Value Measurement March 28, 2020 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 8,333,603 $ 8,333,603 $ - $ - U.S. Government Securities 3,038,100 - 3,038,100 - Corporate Debt 6,269,859 - 6,269,859 - Equity Investments 4,346,642 244,194 - 4,102,448 $ 21,988,204 $ 8,577,797 $ 9,307,959 $ 4,102,448 Fair Value Measurement at December 28, 2019 Using: Total Level 1 Level 2 Level 3 Cash and Cash Equivalents $ 6,029,247 $ 6,029,247 $ - $ - U.S. Government Securities 8,296,870 - 8,296,870 - Corporate Debt 7,456,127 - 7,456,127 - Equity Investments 4,537,159 386,711 - 4,150,448 $ 26,319,403 $ 6,415,958 $ 15,752,997 $ 4,150,448
SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION	Transfers between levels of the fair value hierarchy are reported at the beginning of the reporting period in which they occur. Changes in Level 3 investments were as follows: SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION December 28, 2019 Net unrealized losses Purchases, issuances and settlements Transfers in and or out of Level 3 March 28, 2020 Equity Investments $ 4,537,159 $ (190,517) $ - $ $ 4,346,642

INVENTORY (Tables)

INVENTORY (Tables)	3 Months Ended
	Mar. 28, 2020
Inventory Disclosure [Abstract]
SCHEDULE OF INVENTORY	Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at March 28, 2020 and December 28, 2019: SCHEDULE OF INVENTORY March 28, 2020 December 28, 2019 Raw materials $ 2,522,612 $ 2,630,156 Work-in-process 495,477 711,475 Finished goods 409,418 427,065 Total $ 3,427,507 $ 3,768,696

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)	3 Months Ended
	Mar. 28, 2020
Net loss per share
SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED	The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive or performance conditions have not been met at the end of the period: SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED Three months ended Three months ended March 28, 2020 March 30, 2019 Non-vested restricted common stock 2,377,624 2,150,874

STOCKHOLDERS_ EQUITY AND STOC_2

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)	3 Months Ended
	Mar. 28, 2020
Share-based Payment Arrangement [Abstract]
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY	Restricted stock activity was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Shares Weighted Average Grant Fair Value Balance, December 28, 2019 1,863,124 $ 1.60 Granted 533,000 0.41 Forfeited (18,500) 1.94 Vested — — Balance, March 28, 2020 2,377,624 $ 1.33
SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS	SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS For the three months ended March 28, 2020 Performance price target $ 5.25 $ 6.00 $ 7.00 Expected volatility 48.3 % 48.3 % 48.3 % Interest rate 1.97 % 1.97 % 1.97 % Expected life (years) 3 3 3 Dividend yield — % — % — %
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE	The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three months ended March 28, 2020 and March 30, 2019 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Ended Three Months Ended March 28, 2020 March 30, 2019 Cost of product revenues $ 13,977 $ 32,108 Research and development 55,132 104,730 Selling, general and administrative 89,356 679,004 Total $ 158,465 $ 815,842

ACCRUED WARRANTY (Tables)

ACCRUED WARRANTY (Tables)	3 Months Ended
	Mar. 28, 2020
Guarantees and Product Warranties [Abstract]
SCHEDULE OF ACCRUED WARRANTY	SCHEDULE OF ACCRUED WARRANTY Balance, December 28, 2019 $ 509,000 Additions 225,000 Claims (226,000 ) Balance, March 28, 2020 $ 508,000

CONTRACT ASSETS AND LIABILITI_2

CONTRACT ASSETS AND LIABILITIES (Tables)	3 Months Ended
	Mar. 28, 2020
Contract Assets And Liabilities
SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY	Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY March 28, 2020 December 28, 2019 $ Change % Change Contract assets—current $ 1,394,633 $ 921,082 $ 473,551 51% Contract liabilities and billings in excess of revenues earned (1,229,396 ) (796,794 ) (432,602 ) 54% Contract liabilities—noncurrent (2,643 ) (6,557 ) 3,914 (60)% Net contract assets (liabilities) $ 162,594 $ 117,731 $ 44,863 38%
SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS	The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS Three months ended Three months ended March 28, 2020 March 30, 2019 Point in time 36% 71% Over time 64% 29%

LEASES (Tables)

LEASES (Tables)	3 Months Ended
	Mar. 28, 2020
Leases [Abstract]
SCHEDULE OF LEASE EXPENSE	The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three months ended Three months ended March 28, 2020 March 30, 2019 Operating lease cost $ 283,000 $ 301,000
SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE	At March 28, 2020, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2020 (excluding the three months ended March 28, 2020) $ 893,000 2021 1,050,000 2022 654,000 2023 201,000 Thereafter — Total future lease payments 2,798,000 Less imputed interest (225,000 ) Total $ 2,573,000
SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS	The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheet at March 28, 2020 was as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS March 28, 2020 Operating lease liabilities–current $ 1,059,429 Operating lease liabilities–noncurrent 1,513,520 Total lease liabilities $ 2,572,949
SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES	Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Three months ended March 28, 2020 Cash paid for amounts included in the measurement of operating lease liabilities $ 295,000 Other information related to leases was as follows: March 28, 2020 Weighted Average Discount Rate–Operating Leases 6.16% Weighted Average Remaining Lease Term–Operating Leases (in years) 2.61

SEGMENTS AND DISAGGREGATION O_2

SEGMENTS AND DISAGGREGATION OF REVENUE (Tables)	3 Months Ended
	Mar. 28, 2020
Segment Reporting [Abstract]
SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS	Total long-lived assets by country at March 28, 2020 and December 28, 2019 were: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) March 28, 2020 December 28, 2019 U.S. $ 3,461 $ 3,647 United Kingdom 379 442 China 30 37 Japan 86 102 Total $ 3,956 $ 4,228
SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE	During the three months ended March 28, 2020 and March 30, 2019, the Company derived its sales from the following geographies: SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE March 28, 2020 March 30, 2019 (In thousands, except percentages) Revenue % of Total Revenue % of Total United States $ 6,765 86 % $ 2,406 43 % Other Americas 101 1 18 — Total Americas 6,866 87 2,424 44 Asia-Pacific 664 8 1,872 34 Europe 348 5 1,247 22 Total Revenues $ 7,878 100 % $ 5,543 100 %
SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT	During the three months ended March 28, 2020 and March 30, 2019, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT (In thousands) March 28, 2020 March 30, 2019 Military $ 3,513 $ 1,441 Industrial 2,183 2,503 Consumer 222 646 R&D 1,960 929 Other - 24 Total Revenues $ 7,878 $ 5,543

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	3 Months Ended
	Mar. 28, 2020
Related Party Transactions [Abstract]
SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES	During the three month periods ended March 28, 2020 and March 30, 2019, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three months ended Three months ended March 28, 2020 March 30, 2019 Sales Purchases Sales Purchases Goertek $ — $ — $ — $ 1,246,077 Solos Technology 140,068 9,000 — — RealWear, Inc. — — 525,386 — $ 140,068 $ 9,000 $ 525,386 $ 1,246,077 At March 28, 2020 and December 28, 2019, the Company had the following receivables, contract assets and payables with related parties: March 28, 2020 December 28, 2019 Receivables Contract assets Payables Receivables Contract assets Payables Solos Technology $ 173,128 $ — $ 9,000 $ 283,203 — — RealWear, Inc. 396,848 — — 646,848 — — $ 569,976 $ — $ 9,000 $ 930,051 $ — $ —

BASIS OF PRESENTATION (Details

BASIS OF PRESENTATION (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Dec. 28, 2019
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net Income (Loss) Attributable to Parent	$ (3,595,519)	$ (11,330,927)
Net cash outflows from operations	3,900,000
Net loss	3,600,000
Cash and cash equivalents and marketable debt securities	17,600,000
Proceeds from loans received	$ 2,100,000
Fiscal Period Twenty Ninteen [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net Income (Loss) Attributable to Parent			$ 29,400,000
Net cash outflows from operations			$ 21,000,000

SCHEDULE OF AVAILABLE-FOR-SALE

SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES (Details) - USD ($)	Mar. 28, 2020	Dec. 28, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortized Cost	$ 9,463,682	$ 15,763,527
Unrealized Gains	32,301
Unrealized Losses	(188,024)	(10,530)
Fair Value	9,307,959	15,752,997
U S Government And Agency Backed Securities [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortized Cost	3,005,799	8,304,229
Unrealized Gains	32,301
Unrealized Losses		(7,359)
Fair Value	3,038,100	8,296,870
Corporate Debt [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Amortized Cost	6,457,883	7,459,298
Unrealized Gains
Unrealized Losses	(188,024)	(3,171)
Fair Value	$ 6,269,859	$ 7,456,127

SCHEDULE OF MARKETABLE DEBT SEC

SCHEDULE OF MARKETABLE DEBT SECURITIES (Details)	Mar. 28, 2020USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Less than One year	$ 2,529,970
One to Five years	6,777,989
Total	9,307,959
U S Government And Agency Backed Securities [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Less than One year
One to Five years	3,038,100
Total	3,038,100
Corporate Debt [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Less than One year	2,529,970
One to Five years	3,739,889
Total	$ 6,269,859

SCHEDULE OF FAIR VALUE MEASUREM

SCHEDULE OF FAIR VALUE MEASUREMENT OF FINAL INSTRUMENTS (Details) - USD ($)	Mar. 28, 2020	Dec. 28, 2019
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	$ 21,988,204	$ 26,319,403
Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	8,577,797	6,415,958
Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	9,307,959	15,752,997
Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	4,102,448	4,150,448
Cash and Cash Equivalents [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	8,333,603	6,029,247
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	8,333,603	6,029,247
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
U S Government Securities [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	3,038,100	8,296,870
U S Government Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
U S Government Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	3,038,100	8,296,870
U S Government Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Corporate Debt [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	6,269,859	7,456,127
Corporate Debt [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Corporate Debt [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	6,269,859	7,456,127
Corporate Debt [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Equity Investments [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	4,346,642	4,537,159
Equity Investments [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	244,194	386,711
Equity Investments [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value
Equity Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial Instruments, Owned, at Fair Value	$ 4,102,448	$ 4,150,448

SCHEDULE OF FAIR VALUE, ASSETS

SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION (Details)	3 Months Ended
	Mar. 28, 2020USD ($)
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial instrument fair value, beginnning	$ 26,319,403
Financial instrument fair value, ending	21,988,204
Equity Investments [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Financial instrument fair value, beginnning	4,537,159
Net unrealized losses	(190,517)
Purchases, issuances and settlements
Transfers in and or out of Level 3
Financial instrument fair value, ending	$ 4,346,642

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)	3 Months Ended							12 Months Ended
	Mar. 28, 2020	Mar. 28, 2020	Dec. 28, 2019	Jun. 29, 2019	Mar. 30, 2019	Jun. 30, 2018	Mar. 31, 2018	Dec. 30, 2017	Sep. 30, 2019	May 31, 2019
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Proceeds from Issuance of Common Stock					$ 7,450,000		$ 1,000,000
Unrealized Gain (Loss) on Securities	$ 100,000			$ 800,000
Equity Method Investment, Ownership Percentage	11.00%	11.00%
Equity Method Investments, Fair Value Disclosure	$ 3,500,000	$ 3,500,000
Impairment of equity security			$ 5,200,000
Solos Incorporation [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity Method Investment, Ownership Percentage									20.00%
Series A Warrant [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Gain on fair value of warrant								$ 2,000,000
Loss on warrant						$ 100,000
Series B [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Equity Securities, FV-NI										$ 2,500,000
Warrant [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Ownership percentage in equity investment warrant								15.00%

SCHEDULE OF INVENTORY (Details)

SCHEDULE OF INVENTORY (Details) - USD ($)	Mar. 28, 2020	Dec. 28, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 2,522,612	$ 2,630,156
Work-in-process	495,477	711,475
Finished goods	409,418	427,065
Total	$ 3,427,507	$ 3,768,696

SCHEDULE OF WEIGHTED-AVERAGE CO

SCHEDULE OF WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING DILUTED (Details) - shares	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Net loss per share
Non-vestedrestricted common stock	2,377,624	2,150,874

SCHEDULE OF NON-VESTED RESTRICT

SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY (Details)	3 Months Ended
	Mar. 28, 2020$ / sharesshares
Share-based Payment Arrangement [Abstract]
Number of Shares, Restricted stock Outstanding Beginning | shares	1,863,124
Weighted Average Grant Date Fair Value, Restricted stock Outstanding Beginning | $ / shares	$ 1.60
Number of Shares, Restricted stock Granted | shares	533,000
Weighted Average Grant Date Fair Value, Restricted stock Granted | $ / shares	$ 0.41
Number of Shares, Restricted stock Forfeited | shares	(18,500)
Weighted Average Grant Date Fair Value, Restricted stock Forfeited | $ / shares	$ 1.94
Number of Shares, Restricted stock Vested | shares
Weighted Average Grant Date Fair Value, Restricted stock Vested | $ / shares
Number of Shares, Restricted stock Outstanding Ending | shares	2,377,624
Weighted Average Grant Date Fair Value, Restricted stock Outstanding Ending | $ / shares	$ 1.33

SCHEDULE OF SHARE-BASED PAYMENT

SCHEDULE OF SHARE-BASED PAYMENT AWARD, EMPLOYEE STOCK PURCHASE PLAN, VALUATION ASSUMPTIONS (Details)	3 Months Ended
	Mar. 28, 2020$ / shares
Share-based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance price target	$ 5.25
Expected volatility	48.30%
Interest rate	1.97%
Expected life (years)	3 years
Dividend yield
Share-based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance price target	$ 6
Expected volatility	48.30%
Interest rate	1.97%
Expected life (years)	3 years
Dividend yield
Share-based Payment Arrangement, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance price target	$ 7
Expected volatility	48.30%
Interest rate	1.97%
Expected life (years)	3 years
Dividend yield

SCHEDULE OF STOCK-BASED COMPENS

SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details) - USD ($)	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	$ 158,465	$ 815,842
Cost Of Product Revenues [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	13,977	32,108
Research And Development [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	55,132	104,730
Selling General And Administrative [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based Payment Arrangement, Expense	$ 89,356	$ 679,004

STOCKHOLDERS_ EQUITY AND STOC_3

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($)	Apr. 10, 2019	Mar. 15, 2019	Dec. 31, 2017	Mar. 28, 2020	Mar. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of Stock, Number of Shares Issued in Transaction	700,000	7,300,000
Gross proceeds from registered sale of equity securities	$ 800,000	$ 8,000,000
Shares issued price per share	$ 1.10	$ 1.10
Underwriting discounts and offering expenses from sale of equity		$ 700,000
Minority interest ownership percentage by non controlling owners	0.80%	8.90%
Payments of Stock Issuance Costs	$ 100,000				$ 140,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				533,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized				$ 800,000
Employment Agreement [Member] | Dr John Fan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants expire date			Dec. 31, 2020
Total fair value awards			$ 1,700,000
Employment Agreement [Member] | Dr John Fan [Member] | Price Equal To Or Greater Than Five Point Two Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			640,000
Employment Agreement [Member] | Dr John Fan [Member] | Price Equal To Or Greater Than Six Point Zero [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			150,000
Employment Agreement [Member] | Dr John Fan [Member] | Price Equal To Or Greater Than Seven Point Zero [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period			150,000

SCHEDULE OF ACCRUED WARRANTY (D

SCHEDULE OF ACCRUED WARRANTY (Details)	3 Months Ended
	Mar. 28, 2020USD ($)
Guarantees and Product Warranties [Abstract]
Balance	$ 509,000
Additions	225,000
Claims	(226,000)
Balance	$ 508,000

ACCRUED WARRANTY (Details Narra

ACCRUED WARRANTY (Details Narrative) $ in Millions	3 Months Ended
	Mar. 28, 2020USD ($)
Revenue Benchmark [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Extended Product Warranty Description	The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months
Standard Product Warranty Description	the standard 12 to 18 month warranty.
Warranty [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Product warranty term	The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty.
Deferred revenue	$ 0.1

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) $ in Millions	3 Months Ended
	Mar. 28, 2020USD ($)
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 0.1
Operating Loss Carryforwards	$ 160.5
Net operating loss expiry period	expiring 2022 through 2037
Operating loss carry forwards unlimited	$ 56.9

SCHEDULE OF CONTRACT WITH CUSTO

SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY (Details) - USD ($)	Mar. 28, 2020	Dec. 28, 2019
Contract Assets And Liabilities
Contract assets-current	$ 1,394,633	$ 921,082
Change in Contract assets-current	$ 473,551
Percentage of change in Contract assets-current	51.00%
Contract liabilities and billings in excess of revenues earned	$ (1,229,396)	(796,794)
Change in Contract liabilities and billings in excess of revenues earned	$ (432,602)
Percentage of change in Contract liabilities and billings in excess of revenues earned	54.00%
Contract liabilities-noncurrent	$ (2,643)	(6,557)
Change in Contract liabilities-noncurrent	$ 3,914
Percentage of change in Contract liabilities-noncurrent	(60.00%)
Net contract assets (liabilities)	$ 162,594	$ 117,731
Change in Net contract assets (liabilities)	$ 44,863
Percentage of change in Net contract assets (liabilities)	38.00%

SCHEDULE OF SATISFACTION OF PER

SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATIONS (Details)	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Performance obligation percentage	36.00%	71.00%
Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Performance obligation percentage	64.00%	29.00%

CONTRACT ASSETS AND LIABILITI_3

CONTRACT ASSETS AND LIABILITIES (Details Narrative)	3 Months Ended
	Mar. 28, 2020USD ($)
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]
Increase in contract assets and liabilities	$ 45,000
Contract with Customer, Liability, Revenue Recognized	600,000
Revenue, Remaining Performance Obligation, Amount	8,600,000
Maximum [Member]
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]
Contract with Customer, Liability, Revenue Recognized	$ 100,000

SCHEDULE OF LEASE EXPENSE (Deta

SCHEDULE OF LEASE EXPENSE (Details) - USD ($)	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Leases [Abstract]
Operating lease cost	$ 283,000	$ 301,000

SCHEDULE OF FUTURE LEASE PAYMEN

SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE (Details)	Mar. 28, 2020USD ($)
Leases [Abstract]
2020 (excluding the three months ended March 28, 2020)	$ 893,000
2021	1,050,000
2022	654,000
2023	201,000
Thereafter
Total future lease payments	2,798,000
Less imputed interest	(225,000)
Total	$ 2,573,000

SCHEDULE OF OPERATING LEASE PAY

SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS (Details) - USD ($)	Mar. 28, 2020	Dec. 28, 2019
Leases [Abstract]
Operating lease liabilities–current	$ 1,059,429	$ 1,041,695
Operating lease liabilities–noncurrent	1,513,520	$ 1,791,590
Total lease liabilities	$ 2,572,949

SCHEDULE OF SUPPLEMENTAL INFORM

SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details)	3 Months Ended
	Mar. 28, 2020USD ($)
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 295,000
Weighted Average Discount Rate Operating Leases	6.16%
Weighted Average Remaining Lease TermOperating Leases (in years)	2 years 7 months 9 days

SCHEDULE OF LONG-LIVED ASSETS B

SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS (Details) - USD ($) $ in Thousands	Mar. 28, 2020	Dec. 28, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 3,956	$ 4,228
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	3,461	3,647
United Kingdom [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	379	442
China [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	30	37
Japan [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 86	$ 102

SCHEDULE OF SEGMENT INFORMATION

SCHEDULE OF SEGMENT INFORMATION BY REVENUE TYPE (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 7,878	$ 5,543
Revenue percentage	100.00%	100.00%
United Status [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 6,765	$ 2,406
Revenue percentage	86.00%	43.00%
Other Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 101	$ 18
Revenue percentage	1.00%
Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 6,866	$ 2,424
Revenue percentage	87.00%	44.00%
Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 664	$ 1,872
Revenue percentage	8.00%	34.00%
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 348	$ 1,247
Revenue percentage	5.00%	22.00%

SCHEDULE OF SEGMENT REPORTING I

SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019
Revenue from External Customer [Line Items]
Total Revenues	$ 7,878	$ 5,543
Operating Segments [Member]
Revenue from External Customer [Line Items]
Total Revenues	7,878	5,543
Military [Member] | Operating Segments [Member]
Revenue from External Customer [Line Items]
Total Revenues	3,513	1,441
Industrial [Member] | Operating Segments [Member]
Revenue from External Customer [Line Items]
Total Revenues	2,183	2,503
Consumer [Member] | Operating Segments [Member]
Revenue from External Customer [Line Items]
Total Revenues	222	646
Research and Devlopment [Member] | Operating Segments [Member]
Revenue from External Customer [Line Items]
Total Revenues	1,960	929
Other [Member] | Operating Segments [Member]
Revenue from External Customer [Line Items]
Total Revenues	$ 0	$ 24

SEGMENTS AND DISAGGREGATION O_3

SEGMENTS AND DISAGGREGATION OF REVENUE (Details Narrative)	3 Months Ended
	Mar. 28, 2020
Segment Reporting [Abstract]
Reportable segments	one reportable segment

SCHEDULE OF TRANSACTIONS WITH R

SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES (Details) - USD ($)	3 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Dec. 28, 2019	Dec. 29, 2018
Related Party Transaction [Line Items]
Revenue from Related Parties	$ 140,068	$ 525,386
Related Party Transaction, Purchases from Related Party	9,000	1,246,077
Accounts Receivable, Related Parties	569,976			$ 930,051
Contract with Customer, Asset, Net, Current
Accounts Payable, Related Parties	9,000
Goertek [Member]
Related Party Transaction [Line Items]
Revenue from Related Parties
Related Party Transaction, Purchases from Related Party		1,246,077
Solos Technology [Member]
Related Party Transaction [Line Items]
Revenue from Related Parties	140,068
Related Party Transaction, Purchases from Related Party	9,000
Accounts Receivable, Related Parties	173,128			283,203
Contract with Customer, Asset, Net, Current
Accounts Payable, Related Parties	9,000
Real Wear Inc [Member]
Related Party Transaction [Line Items]
Revenue from Related Parties		525,386
Related Party Transaction, Purchases from Related Party
Accounts Receivable, Related Parties	396,848			$ 646,848
Contract with Customer, Asset, Net, Current
Accounts Payable, Related Parties

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	Apr. 21, 2020	Mar. 28, 2020
Subsequent Event [Line Items]
Proceeds from Loans		$ 2,100,000
Subsequent Event [Member] | P P P Loan [Member] | Individual Employee [Member] | Maximum [Member]
Subsequent Event [Line Items]
Employee-related Liabilities	$ 100,000
Subsequent Event [Member] | P P P Loan [Member] | Employee [Member]
Subsequent Event [Line Items]
Employee-related Liabilities	$ 100,000
Payroll costs, description	Not more than 25% of the forgiven amount may be for non-payroll costs.
Subsequent Event [Member] | Rockland Trust Company [Member] | P P P Loan [Member]
Subsequent Event [Line Items]
Proceeds from Loans	$ 2,100,000
Debt Instrument, Maturity Date	Apr. 20, 2022
Debt Instrument, Interest Rate, Stated Percentage	1.00%